Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: XK469R in Treating Patients With Refractory Hematologic Cancer [Phase 1]
Phase 1 trial update reporting initial safety and tolerability findings for XK469R in patients with refractory hematologic cancers.
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: 6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia [Phase 1]
NCI-sponsored Phase 1 clinical trial update of 6-Hydroxymethylacylfulvene (Irofulven) in patients with refractory acute myeloid leukemia, ac…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction [Phase 1]
This clinical trial update summarizes a Phase 1 study of Imatinib Mesylate in patients with advanced cancer and liver dysfunction, which has…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Collection and Banking of Leukemia Cells MDS/AML [NA]
A completed clinical trial focusing on the collection and banking of leukemia cells in patients with myelodysplastic syndrome and acute myel…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia [Phase 1, Phase 2]
This update reports on a Phase 1/2 clinical trial evaluating the combination of bortezomib, daunorubicin, and cytarabine in older patients w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: Tipifarnib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]
Phase 1 trial data on tipifarnib in relapsed or refractory acute myeloid leukemia have been reported with the study status marked as complet…
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia [Phase 1]
Phase 1 study of augmerosen with fludarabine and cytarabine in patients with refractory or relapsed acute myeloid leukemia or acute lymphobl…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: 3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies [Phase 1]
Phase 1 trial evaluating the combination of triapine (3-AP) with high-dose cytarabine in adults with advanced hematologic malignancies has c…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 2]
Phase 2 trial of idarubicin and cytarabine with or without bevacizumab for newly diagnosed acute myeloid leukemia was terminated.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Cilengitide in Treating Patients With Acute Myeloid Leukemia [Phase 2]
A Phase 2 trial of cilengitide for acute myeloid leukemia was terminated.
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome [Phase 1]
Phase 1 clinical trial update (completed) of PS-341 (bortezomib) in patients with refractory or relapsed acute myeloid leukemia, acute lymph…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia [Phase 1]
Phase 1 study evaluating a rebeccamycin analog in adults with relapsed or refractory acute myeloid leukemia, myelodysplastic syndromes, acut…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase [Phase 2]
A Phase 2 trial evaluating CCI-779 (temsirolimus) in adults with relapsed or refractory acute myeloid leukemia, acute lymphoblastic leukemia…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia [Phase 1]
Phase 1 study of BMS-214662 in patients with various leukemias and myelodysplastic syndromes has completed enrollment; the document lists th…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy [Phase 1, Phase 2]
This clinical trial update reports on a completed Phase 1/2 study of liposomal daunorubicin combined with SU5416 for hematologic cancers tha…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in Patients With Poor-risk Acute Myelogenous Leukemia (AML) [Phase 1]
A Phase 1 trial evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of oral AT-406 in combination with daunorubicin …
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Decitabine in Treating Children With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia [Phase 1]
A Phase 1 pediatric trial evaluates decitabine for relapsed or refractory acute myeloid leukemia and acute lymphoblastic leukemia, including…
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia [Phase 1]
A Phase 1 trial evaluating sodium salicylate in patients with advanced myelodysplastic syndromes, acute myeloid leukemia, or chronic lymphoc…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [Phase 3]
Phase 3 trial evaluating combination chemotherapy with or without bone marrow transplantation in children with acute myeloid leukemia or mye…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Raltitrexed in Treating Children With Refractory Acute Leukemia [Phase 1]
This document provides an update on a Phase 1 clinical trial of Raltitrexed for refractory acute leukemia in children, including recurrent c…
-
CLINICAL_TRIALS trial_result · 2013-01-15Clinical Trial Update: S0432 Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia [Phase 2]
Phase 2 clinical trial update on tipifarnib (S0432) in older adults with acute myeloid leukemia; the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-11Clinical Trial Update: SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes [Phase 1]
This Phase 1 trial evaluated SB-715992 in adults with various acute leukemias, chronic myeloid leukemia in blast phase, and advanced myelody…
-
CLINICAL_TRIALS trial_result · 2013-01-09Clinical Trial Update: A Phase II Study Of The Farnesyltransferase Inhibitor ZANESTRA (R115777, NSC #702818, IND #58,359) In Complete Remission Following Induction And/Or Consolidation Chemotherapy In Adults With Poor-Risk Acute Myelogenous Leukemia (AML) And High-Risk Myelodysplasia (MDS) [Phase 2]
This status update describes results from a Phase II study of the farnesyltransferase inhibitor tipifarnib (Zarnestra) in adults with poor-r…
-
CLINICAL_TRIALS trial_result · 2013-01-09Clinical Trial Update: Sorafenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia [Phase 1]
A Phase 1 trial evaluating sorafenib in adults with relapsed or refractory acute myeloid leukemia, acute lymphoblastic leukemia, or chronic …
-
CLINICAL_TRIALS trial_result · 2013-01-09Clinical Trial Update: Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer [Phase 1]
Phase 1 study assessing the safety of adding sargramostim (GM-CSF) to chemotherapy in patients with refractory myeloid cancers; the trial ha…